Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mimetis

Mimetis
2013 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$8.25K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of biomimetic bone graft substitutes designed to achieve complete bone regeneration without loss of volume. The company's biomimetic bone graft substitutes are similar to those encountered in the human body in order to mimic naturally occurring processes and match the features of natural bone, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Formerly Known As
Subtilis Biomaterials
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
  • Avenue Universitat Autònoma, 23
  • Cerdanyola del Valles 23
  • 08290 Barcelona
  • Spain

+34 644 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mimetis’s full profile, request a free trial.

Mimetis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Grant 12-Mar-2014 $8.25K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Mimetis Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Barcelona Activa Accelerator/Incubator 000 0000 000000 0
Biocat Accelerator/Incubator 000 0000 000000 0
Caixa Capital Risc Corporate Venture Capital 000 0000 000000 0

Mimetis Executive Team (4)

Name Title Board
Seat
Contact
Info
David Pastorino Co-Founder & Chief Executive Officer
Maria-Pau Ginebra Ph.D Co-Founder & President
Yassine Maazouz Chief Technology Officer & Co-Founder
Xavier Gil Co-Founder